Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia.

•GNAO1 mutations are associated with life-threatening exacerbations of hyperkinesia.•Pallidal deep brain stimulation should be considered as first-line treatment in hyperkinetic exacerbations.•WES can rapidly streamline pathogenic mutations in disease associated genes in clinically complex movement disorders.